HEXAOM (ALHEX.PA) Fundamental Analysis & Valuation

EPA:ALHEX • FR0004159473

Current stock price

35.3 EUR
+1.8 (+5.37%)
Last:

This ALHEX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALHEX.PA Profitability Analysis

1.1 Basic Checks

  • ALHEX had positive earnings in the past year.
  • In the past year ALHEX has reported a negative cash flow from operations.
  • Of the past 5 years ALHEX 4 years were profitable.
  • Each year in the past 5 years ALHEX had a positive operating cash flow.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.46%, ALHEX is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • ALHEX's Return On Equity of 3.94% is in line compared to the rest of the industry. ALHEX outperforms 54.29% of its industry peers.
  • The Return On Invested Capital of ALHEX (3.70%) is comparable to the rest of the industry.
  • ALHEX had an Average Return On Invested Capital over the past 3 years of 8.77%. This is in line with the industry average of 9.43%.
  • The last Return On Invested Capital (3.70%) for ALHEX is well below the 3 year average (8.77%), which needs to be investigated, but indicates that ALHEX had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROIC 3.7%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.46%, ALHEX is in line with its industry, outperforming 48.57% of the companies in the same industry.
  • ALHEX's Profit Margin has declined in the last couple of years.
  • ALHEX has a Operating Margin of 2.30%. This is comparable to the rest of the industry: ALHEX outperforms 42.86% of its industry peers.
  • ALHEX's Operating Margin has declined in the last couple of years.
  • ALHEX's Gross Margin of 21.14% is on the low side compared to the rest of the industry. ALHEX is outperformed by 74.29% of its industry peers.
  • In the last couple of years the Gross Margin of ALHEX has remained more or less at the same level.
Industry RankSector Rank
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. ALHEX.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALHEX is creating some value.
  • ALHEX has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ALHEX has been reduced compared to a year ago.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.14 indicates that ALHEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ALHEX has a Altman-Z score of 2.14. This is comparable to the rest of the industry: ALHEX outperforms 57.14% of its industry peers.
  • A Debt/Equity ratio of 0.40 indicates that ALHEX is not too dependend on debt financing.
  • ALHEX has a Debt to Equity ratio (0.40) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.14
ROIC/WACC0.53
WACC7.01%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • ALHEX has a Current Ratio of 1.31. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHEX has a Current ratio (1.31) which is comparable to the rest of the industry.
  • ALHEX has a Quick Ratio of 1.31. This is a bad value and indicates that ALHEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALHEX's Quick ratio of 0.99 is fine compared to the rest of the industry. ALHEX outperforms 65.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.99
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. ALHEX.PA Growth Analysis

3.1 Past

  • ALHEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.84%.
  • Measured over the past years, ALHEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.22% on average per year.
  • ALHEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.53%.
  • Measured over the past years, ALHEX shows a decrease in Revenue. The Revenue has been decreasing by -9.93% on average per year.
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%

3.2 Future

  • The Earnings Per Share is expected to grow by 36.47% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALHEX will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.
EPS Next Y4.15%
EPS Next 2Y35.61%
EPS Next 3Y36.47%
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y-0.74%
Revenue Next 3Y7.79%
Revenue Next 5Y3.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

4

4. ALHEX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALHEX is valuated quite expensively with a Price/Earnings ratio of 26.95.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALHEX is on the same level as its industry peers.
  • ALHEX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.42, which is the current average of the S&P500 Index.
  • ALHEX is valuated reasonably with a Price/Forward Earnings ratio of 9.09.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHEX indicates a somewhat cheap valuation: ALHEX is cheaper than 65.71% of the companies listed in the same industry.
  • ALHEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.24.
Industry RankSector Rank
PE 26.95
Fwd PE 9.09
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ALHEX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.42
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ALHEX's earnings are expected to grow with 36.47% in the coming years.
PEG (NY)6.5
PEG (5Y)N/A
EPS Next 2Y35.61%
EPS Next 3Y36.47%

3

5. ALHEX.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.38%, ALHEX has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.92, ALHEX has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, ALHEX pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.38%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 2026 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y35.61%
EPS Next 3Y36.47%
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

ALHEX.PA Fundamentals: All Metrics, Ratios and Statistics

HEXAOM

EPA:ALHEX (4/24/2026, 7:00:00 PM)

35.3

+1.8 (+5.37%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners15.62%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap244.98M
Revenue(TTM)617.81M
Net Income(TTM)9.04M
Analysts86
Price Target46.67 (32.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.38%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.55%
PT rev (3m)0.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.67%
EPS NY rev (3m)18.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 26.95
Fwd PE 9.09
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB 2.42
EV/EBITDA 6.42
EPS(TTM)1.31
EY3.71%
EPS(NY)3.88
Fwd EY11%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS89.02
BVpS33.03
TBVpS14.6
PEG (NY)6.5
PEG (5Y)N/A
Graham Number31.2014 (-11.61%)
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROCE 4.7%
ROIC 3.7%
ROICexc 6.23%
ROICexgc 17.99%
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
FCFM N/A
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexgc growth 3Y-17.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 2.97
Cap/Depr 27.37%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.99
Altman-Z 2.14
F-Score4
WACC7.01%
ROIC/WACC0.53
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
EPS Next Y4.15%
EPS Next 2Y35.61%
EPS Next 3Y36.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%
Revenue Next Year-11.32%
Revenue Next 2Y-0.74%
Revenue Next 3Y7.79%
Revenue Next 5Y3.02%
EBIT growth 1Y-50.48%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year80.1%
EBIT Next 3Y49.28%
EBIT Next 5YN/A
FCF growth 1Y-136.13%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-114.31%
OCF growth 3Y-21.91%
OCF growth 5YN/A

HEXAOM / ALHEX.PA Fundamental Analysis FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALHEX.PA.


Can you provide the valuation status for HEXAOM?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for HEXAOM?

HEXAOM (ALHEX.PA) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for ALHEX stock?

The Earnings per Share (EPS) of HEXAOM (ALHEX.PA) is expected to grow by 4.15% in the next year.


How sustainable is the dividend of HEXAOM (ALHEX.PA) stock?

The dividend rating of HEXAOM (ALHEX.PA) is 3 / 10 and the dividend payout ratio is 0%.